The older rheumatoid arthritis patients: who are they and how should they be treated?
Authors: Ranganath, Veena K; Amjadi, Sogol; Melikterminas, Edmond; Furst, Daniel E
Source: Aging Health, Volume 6, Number 5, October 2010 , pp. 533-549(17)
Publisher: Future Medicine
Abstract:Differences in clinical characteristics of older and younger rheumatoid arthritis (RA) patients have led some researchers to believe that RA in older patients is a distinct clinical entity and requires specialized therapeutic management. Whether or not there are any differences in clinical features and prognosis between older and younger RA patients, there is general consensus that RA should be treated aggressively early in the course of the disease to achieve the best clinical outcome. For this reason, all patients, irrespective of age, are treated with commonly used disease-modifying antirheumatic drugs/biologic agents. Although the data are limited, published safety and efficacy papers on older RA patients suggest that most disease-modifying antirheumatic drugs/biologic agents have similar efficacy and safety outcomes to younger RA patients. However, due to multiple comorbidities, older RA patients may be at a higher risk for adverse drug reactions.
Document Type: Research Article
Affiliations: 1University of California, Los Angeles, 1000 Veteran Avenue Rehab Building 32–59, Los Angeles, CA 90095, USA
Publication date: October 2010
- Aging Health leading coverage of current and emerging topics relating to the safe and effective management of therapy in the elderly, all subject to rigorous peer review. The journal focuses on the most important advances and highlights their relevance in the clinical setting. The journal has been designed to deliver essential concise information in an easily assimilable format - vital for the increasingly time-constrained professional.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Information for Librarians
- E-Access Trials
- ingentaconnect is not responsible for the content or availability of external websites